CVS HEALTH Corp SEC filings CVS

CVS HEALTH Corp has 1,003 filings in SEC EDGAR's recent list, going back to Dec 19, 2017. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

CVS HEALTH Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Regulation FD disclosure
Nov 4, 2026 Nov 4, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 17, 2026 Aug 13, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
11-K Employee savings plan report Jun 23, 2026 Dec 31, 2025
S-8 Employee stock plan registration May 22, 2026 —
S-3ASR Automatic shelf registration May 22, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 18, 2026 May 14, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 3, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 3, 2026 —
DEF 14A Proxy statement Apr 3, 2026 May 14, 2026
8-K Current report
Officer or director change
Mar 19, 2026 Mar 18, 2026
10-K Annual report Feb 10, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 10, 2026 Feb 10, 2026
8-K Current report
Regulation FD disclosure
Dec 9, 2025 Dec 9, 2025
8-K Current report
Other events
Nov 20, 2025 Nov 20, 2025
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
8-K Current report
Other events
Sep 22, 2025 Sep 22, 2025
8-K Current report
Other events
Aug 15, 2025 Aug 11, 2025
424B2 Prospectus Aug 12, 2025 —
FWP Free writing prospectus Aug 12, 2025 —
424B3 Prospectus Aug 11, 2025 —
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 31, 2025 Jul 31, 2025
11-K Employee savings plan report Jun 26, 2025 Dec 31, 2024
8-K Current report
Shareholder vote results
May 20, 2025 May 15, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 8, 2025 Apr 7, 2025
ARS Annual report to shareholders Apr 4, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 4, 2025 —
DEF 14A Proxy statement Apr 4, 2025 May 15, 2025
10-K Annual report Feb 12, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 12, 2025 Feb 12, 2025
8-K Current report
Other events
Dec 17, 2024 Dec 16, 2024
8-K Current report
Other events
Dec 10, 2024 Dec 10, 2024
8-K Current report
Other events
Dec 9, 2024 Dec 9, 2024
8-K Current report
Other events
Dec 6, 2024 Dec 6, 2024
424B2 Prospectus Dec 5, 2024 —
8-K Current report
Other events
Dec 5, 2024 Dec 3, 2024
FWP Free writing prospectus Dec 4, 2024 —
424B3 Prospectus Dec 3, 2024 —
8-K Current report
Other events
Dec 2, 2024 Dec 2, 2024
UPLOAD Letter from the SEC Nov 21, 2024 —
CORRESP Letter to the SEC Nov 21, 2024 —
UPLOAD Letter from the SEC Nov 19, 2024 —
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Nov 18, 2024 Nov 12, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 6, 2024 Nov 6, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Oct 18, 2024 Oct 17, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
11-K Employee savings plan report Jun 20, 2024 Dec 31, 2023
S-8 Employee stock plan registration May 23, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
May 22, 2024 May 16, 2024
8-K Current report
Other events
May 9, 2024 May 9, 2024
8-K Current report
Other events
May 8, 2024 May 7, 2024
424B2 Prospectus May 8, 2024 —
FWP Free writing prospectus May 7, 2024 —
424B3 Prospectus May 7, 2024 —
10-Q Quarterly report May 1, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 1, 2024 May 1, 2024
PX14A6G Filing Apr 16, 2024 —
ARS Annual report to shareholders Apr 5, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 5, 2024 —
DEF 14A Proxy statement Apr 5, 2024 May 16, 2024
8-K Current report
Regulation FD disclosure
Mar 5, 2024 Mar 5, 2024
10-K Annual report Feb 7, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 7, 2024 Feb 7, 2024
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Jan 5, 2024 Jan 5, 2024
8-K Current report
Regulation FD disclosure
Dec 5, 2023 Dec 5, 2023
10-Q Quarterly report Nov 1, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 1, 2023 Nov 1, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 16, 2023 Oct 13, 2023
8-K Current report
Regulation FD disclosure
Oct 13, 2023 Oct 13, 2023
8-K Current report
Officer or director change
Sep 21, 2023 Sep 20, 2023
8-K Current report
Regulation FD disclosure
Sep 11, 2023 Sep 11, 2023
8-K Current report
Regulation FD disclosure
Aug 23, 2023 Aug 23, 2023
8-K Current report
Regulation FD disclosure
Aug 17, 2023 Aug 17, 2023
S-8 Employee stock plan registration Aug 2, 2023 —
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Officer or director change
Jul 20, 2023 Jul 19, 2023
11-K Employee savings plan report Jun 27, 2023 Dec 31, 2022
8-K Current report
Other events
Jun 2, 2023 Jun 2, 2023
424B2 Prospectus Jun 1, 2023 —
8-K Current report
Other events
Jun 1, 2023 May 30, 2023
8-K Current report
Regulation FD disclosure
May 31, 2023 May 31, 2023
FWP Free writing prospectus May 30, 2023 —
424B3 Prospectus May 30, 2023 —
S-3ASR Automatic shelf registration May 25, 2023 —
8-K Current report
Other events
May 25, 2023 May 25, 2023
8-K Current report
Shareholder vote results
May 24, 2023 May 18, 2023
UPLOAD Letter from the SEC May 15, 2023 —
CORRESP Letter to the SEC May 15, 2023 —
UPLOAD Letter from the SEC May 11, 2023 —
PX14A6G Filing May 3, 2023 —
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
S-8 Employee stock plan registration May 2, 2023 —
8-K Current report
Material agreement, New debt, Other events
May 2, 2023 May 1, 2023
PX14A6G Filing Apr 26, 2023 —
ARS Annual report to shareholders Apr 7, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 7, 2023 —
DEF 14A Proxy statement Apr 7, 2023 —
8-K Current report
Regulation FD disclosure
Mar 30, 2023 Mar 30, 2023
S-8 Employee stock plan registration Mar 29, 2023 —
DFAN14A Soliciting material Mar 7, 2023 —
8-K Current report
Other events
Feb 21, 2023 Feb 21, 2023
8-K Current report
Other events
Feb 15, 2023 Feb 13, 2023
424B2 Prospectus Feb 15, 2023 —
FWP Free writing prospectus Feb 13, 2023 —
424B3 Prospectus Feb 13, 2023 —
DFAN14A Proxy statement pursuant to section 14(a) Feb 9, 2023 —
8-K Current report
Material agreement
Feb 8, 2023 Feb 8, 2023
DFAN14A Proxy statement pursuant to section 14(a) Feb 8, 2023 —
10-K Annual report Feb 8, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 8, 2023 Feb 8, 2023
8-K Current report
Regulation FD disclosure
Feb 8, 2023 Feb 8, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 23, 2023 Jan 18, 2023
8-K Current report
Results of operations
Jan 9, 2023 Jan 9, 2023
8-K Current report
Bylaw or fiscal year change, Other events
Nov 21, 2022 Nov 17, 2022
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 2, 2022 Nov 2, 2022
8-K Current report
Other events
Oct 20, 2022 Oct 19, 2022
8-K Current report
Other events
Oct 6, 2022 Oct 6, 2022
8-K Current report
Officer or director change
Sep 13, 2022 Sep 12, 2022
8-K Current report
Regulation FD disclosure
Sep 13, 2022 Sep 13, 2022
DEFA14A Additional proxy material Sep 7, 2022 —
DEFA14A Additional proxy material Sep 6, 2022 —
8-K Current report
Other events
Sep 6, 2022 Sep 2, 2022
8-K Current report
Material agreement
Sep 6, 2022 Sep 2, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Other events
Aug 2, 2022 Aug 2, 2022
8-K Current report
Other events
Jul 15, 2022 Jul 15, 2022
11-K Employee savings plan report Jun 23, 2022 Dec 31, 2021
8-K Current report
Regulation FD disclosure
Jun 9, 2022 Jun 9, 2022
8-K Current report
Shareholder vote results
May 16, 2022 May 11, 2022
8-K Current report
Other events
May 16, 2022 May 16, 2022
PX14A6G Filing May 11, 2022 —
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
PX14A6G Filing Apr 6, 2022 —
DEFA14A Additional proxy material Apr 1, 2022 —
DEF 14A Proxy statement Apr 1, 2022 May 11, 2022
8-K Current report
Other events
Mar 30, 2022 Mar 30, 2022
8-K Current report
Officer or director change
Mar 25, 2022 Mar 21, 2022
8-K Current report
Officer or director change
Mar 10, 2022 Mar 8, 2022
10-K Annual report Feb 9, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 9, 2022 Feb 9, 2022
8-K Current report
Results of operations
Jan 11, 2022 Jan 11, 2022
8-K Current report
Other events
Dec 13, 2021 Dec 13, 2021
8-K Current report
Regulation FD disclosure
Dec 9, 2021 Dec 9, 2021
8-K Current report
Impairment, Regulation FD disclosure
Nov 18, 2021 Nov 17, 2021
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 3, 2021 Nov 3, 2021
8-K Current report
Other events
Aug 23, 2021 Aug 23, 2021
8-K Current report
Other events
Aug 18, 2021 Aug 18, 2021
8-K Current report
Other events
Aug 11, 2021 Aug 9, 2021
424B2 Prospectus Aug 11, 2021 —
FWP Free writing prospectus Aug 9, 2021 —
424B3 Prospectus Aug 9, 2021 —
8-K Current report
Other events
Aug 9, 2021 Aug 9, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
11-K Employee savings plan report Jun 24, 2021 Dec 31, 2020
8-K Current report
Officer or director change
Jun 10, 2021 Jun 9, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
May 18, 2021 May 17, 2021
8-K Current report
Shareholder vote results
May 17, 2021 May 13, 2021
10-Q Quarterly report May 4, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 4, 2021 May 4, 2021
DEFA14A Additional proxy material Apr 2, 2021 —
DEF 14A Proxy statement Apr 2, 2021 May 13, 2021
10-K Annual report Feb 16, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 16, 2021 Feb 16, 2021
8-K Current report
Other events
Dec 21, 2020 Dec 21, 2020
8-K Current report
Other events
Dec 16, 2020 Dec 16, 2020
8-K Current report
Other events
Dec 9, 2020 Dec 7, 2020
424B2 Prospectus Dec 9, 2020 —
FWP Free writing prospectus Dec 7, 2020 —
424B3 Prospectus Dec 7, 2020 —
8-K Current report
Other events
Dec 7, 2020 Dec 7, 2020
8-K Current report
Officer or director change
Nov 6, 2020 Nov 5, 2020
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 6, 2020 Nov 6, 2020
8-K Current report
Regulation FD disclosure
Sep 25, 2020 Sep 25, 2020
8-K Current report
Regulation FD disclosure
Sep 15, 2020 Sep 15, 2020
8-K Current report
Other events
Aug 26, 2020 Aug 26, 2020
8-K Current report
Other events
Aug 21, 2020 Aug 21, 2020
8-K Current report
Other events
Aug 14, 2020 Aug 12, 2020
424B2 Prospectus Aug 14, 2020 —
FWP Free writing prospectus Aug 12, 2020 —
424B3 Prospectus Aug 12, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Retail-Drug Stores and Proprietary Stores (SIC 5912)
Listed as
CVS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Woonsocket, RI
SEC filer status
Large accelerated filer
SEC CIK
64803
Former names
CVS CAREMARK CORP (until Sep 3, 2014); CVS/CAREMARK CORP (until May 8, 2007); CVS CORP (until Mar 22, 2007); MELVILLE CORP (until Jan 10, 1997)

Other Retail-Drug Stores and Proprietary Stores companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.